SNORD81: A Potential Drug Target and Biomarker (G26769)

Target Name: SNORD81

NCBI ID: G26769

SNORD81

Other Name(s): RNU104 | U81 | Z23 | small nucleolar RNA, C/D box 81 | Small nucleolar RNA, C/D box 81

SNORD81: A Potential Drug Target and Biomarker

SNORD81 (RNU104) is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed light on its role in various biological processes.

SNORD81 is a RNA molecule that consists of 81 amino acid residues. It is characterized by a stem-loop structure, which is a common type of RNA structure that is found in various proteins and ribosomes. The stem-loop region of SNORD81 is composed of three loops of amino acids that are connected by a central stem region. This structure gives SNORD81 a unique shape and allows it to interact with various proteins.

One of the key features of SNORD81 is its ability to interact with the protein encoded by the RNA-protein interactions gene (SPOP). SPOP is a gene that has been shown to play a role in the regulation of cellular processes, including cell growth, differentiation, and apoptosis. By interacting with SPOP, SNORD81 has been shown to regulate the activity of the gene and control the production of proteins that are involved in cell growth and survival.

In addition to its interaction with SPOP, SNORD81 has also been shown to interact with the protein encoded by the zinc finger gene (ZNF2). ZNF2 is a gene that has been linked to various diseases, including cancer. By interacting with ZNF2, SNORD81 has been shown to regulate the activity of ZNF2 and control the production of proteins that are involved in cell growth, differentiation, and apoptosis.

SNORD81's ability to interact with multiple proteins has made it an attractive target for researchers to study. By using techniques such as RNA interference and live cell imaging, researchers have been able to demonstrate the role of SNORD81 in various biological processes, including cell growth, differentiation, and apoptosis.

One of the most promising aspects of SNORD81 is its potential as a drug target. By interacting with multiple proteins, SNORD81 has been shown to play a role in the regulation of cellular processes, including cell growth, differentiation, and apoptosis. This makes it an attractive target for drugs that are designed to inhibit these processes or enhance them in ways that are beneficial.

SNORD81 has also been shown to be involved in the regulation of gene expression. By interacting with the protein encoded by the RNA-protein interactions gene (SPOP), SNORD81 has been shown to regulate the activity of SPOP and control the production of proteins that are involved in cell growth and survival. This suggests that SNORD81 may be a useful biomarker for diseases associated with overactive SPOP signaling, such as cancer.

In addition to its potential as a drug target, SNORD81 has also been shown to be involved in the regulation of cellular processes that are important for human health. For example, studies have shown that SNORD81 is involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs.

Overall, SNORD81 is a unique and promising molecule that has the potential to be a drug target and biomarker for a variety of diseases. Its unique stem-loop structure and ability to interact with multiple proteins make it an attractive target for researchers to study, and its potential as a drug target and biomarker make it an exciting area of research. Further studies are needed to fully understand the role of SNORD81 in various biological processes and to determine its potential as a drug.

Protein Name: Small Nucleolar RNA, C/D Box 81

The "SNORD81 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD81 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets